pMMR
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (NCT04659382) | Federation Francophone de Cancerologie Digestive | 2020-10-07 |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (NCT04527068) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-20 |
| Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma. (NCT04483219) | China Medical University, China | 2020-07-24 |
Track pMMR automatically
Every clearance here is in the API, with alerts when new ones post.